ArticleJournal of hepatology2019
Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance.
Sabrina J Merat et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papercites it